Lyra Therapeutics (LYRA) EBITDA Margin Growth (1y) (2022 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1,536.00 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -957.00 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 8,807.00 |
| 10 | Lyra Therapeutics | - | - | - | -9.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -9.40 Mn |
| Sep 30, 2025 | -1.79 Mn |
| Jun 30, 2025 | 398,958.00 |
| Mar 31, 2025 | -44,869.00 |
| Dec 31, 2024 | 509,075.00 |
| Sep 30, 2024 | -320,306.00 |
| Jun 30, 2024 | -464,019.00 |
| Mar 31, 2024 | -25,180.00 |
| Dec 31, 2023 | 11.90 Mn |
| Sep 30, 2023 | 123,975.00 |
| Jun 30, 2023 | -67,694.00 |
| Mar 31, 2023 | -142,491.00 |
| Dec 31, 2022 | -12.43 Mn |
| Sep 30, 2022 | 7.49 Mn |